Signal active
Investment Firm
Overview
CSEM is a private, non profit Swiss company for applied research, including technology, strategy and innovation consulting, focused on generating value for a sustainable world.
They aim to be one of the best innovation centers worldwide, providing novel applications and solutions to their customers by developing and applying their technology platforms in micro-, nano- and information technologies, thus adding value to the results of research. Their research activities - financed by public funds - combined with the research results of their academic partners, help us to develop their technology platforms for the benefit of their industrial customers and their start-ups.
They are aware that collaborating with other innovation centers and research entities is crucial. With this in mind, they have built up a strong national and international network. They work together with CEA/Léti in France, the Fraunhofer Gesellschaft (Mikroelektronische Allianz) in Germany and VTT in Finland. Together with these institutions, CSEM created HTA (Heterogeneous Technology Alliance), to prepare for the next generation of technology. Their research strategy is based on extensive market research, and helps us to develop technologies today which will be needed in the future.
While research activities remain one of the cornerstones of CSEM, they never lose sight of the overriding importance of their customers - it is they who provide us with invaluable insights into global markets.
Highlights
1984
Consulting
501-1000
3
2
2
Early Stage Venture
N/A
Location
Neuchâtel, Neuchatel, Switzerland, Europe
Contact Information
Social
Profile Resume
CSEM, established in 1984 and headquartered in Switzerland, Europe., specializes in Early Stage Venture investments across Semiconductor, Wireless, Manufacturing, Information Technology, Venture Capital, Life Science, Health Care, Financial Services, Finance, Software. The organization boasts a portfolio of 3 investments, with an average round size of $7.2M and 2 successful exits. Their recent investments include Xemics, VI Partners, Emertec, Avalon Photonics, Viventures. The highest investment round they participated in was $510.0M. Among their most notable exits are Xemics and VI Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
3
0
2
2
Investments
3
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jan 15, 1999 | Xemics | Semiconductor | 11.9M |
May 14, 2003 | Avalon Photonics | Manufacturing | 5.5M |
Jan 01, 2019 | - | - | 4.3M |
Exits
2
Funding Timeline
3
0
0
Funding Rounds
3
CSEM has raised 3 rounds. Their latest funding was raised on Jan 01, 2019 from a Series A - MESA Imaging round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jan 15, 1999 | Venture Round - Xemics | - | 11.9M | - |
May 14, 2003 | Venture Round - Avalon Photonics | - | 5.5M | - |
Jan 01, 2019 | Series A - MESA Imaging | - | 4.3M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
News
Aug 21, 2024
BioAlps - CSEM announced Andrea Dunbar as new CTO
News
Jul 25, 2024
BioAlps - CSEM develops a pioneering implant to support reproductive medicine
News
Jul 10, 2024
Startupticker-Ch - Four new ventures set to shine within CSEM
News
Feb 22, 2024
BioAlps - CSEM and ClexBio create a bioreactor to manufacture tissue-engineered cardiovascular implants
News
Feb 08, 2024
BioAlps - CSEM Inventor Award granted to spaceCoder
News
Feb 05, 2024
eeNews Europe - CSEM splits its systems business in two